Short report: Delayed anemia after treatment with injectable artesunate in the Democratic Republic of the Congo: a manageable issue

American Journal of Tropical Medicine and Hygiene

Volumn 91, Issue 4, 2014, Pages 821-823

  Burri, Christian ^a   Ferrari, Giovanfrancesco ^a   Ntuku, Henry Maggi ^a   Kitoto, Antoinette Tshefu ^b   Duparc, Stephan ^c   Hugo, Pierre ^c   Mitembo, Didier Kalemwa ^a   Lengeler, Christian ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF KINSHASA   (Congo)

^c Medicines for Malaria Venture   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; HEMOGLOBIN; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; CHILD; DEMOCRATIC REPUBLIC CONGO; FOLLOW UP; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; PRESCHOOL CHILD; CHEMICALLY INDUCED; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALARIA, FALCIPARUM; MORTALITY; PARASITOLOGY; PLASMODIUM FALCIPARUM; TIME;

ANEMIA, HEMOLYTIC; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DEMOCRATIC REPUBLIC OF THE CONGO; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; TIME FACTORS;

EID: 84907696923     PISSN: 00029637     EISSN: 14761645     Source Type: Journal    
DOI: 10.4269/ajtmh.14-0149     Document Type: Article

References (8)

1. World Health Organization, 2006. Guidelines for the Treatment of Severe Malaria. Geneva: World Health Organization.
2. World Health Organization, 2011.Guidelines for Treatment of Malaria. Second edition. Geneva: World Health Organization. Available at: http://www.who.int/malaria/publications/atoz/9789241547925/en. Accessed January 27, 2014.
3. World Health Organization, 2012. World Malaria Report 2012, Section 8.5, Cases and Deaths Averted 2001-2010. Geneva: World Health Organization.
4. Centers for Disease Control and Prevention, 2013. Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria-worldwide, 2010-2012. MMWR Morb Mortal Wkly Rep 62: 5-8.
5. Rolling T, Agbenyega T, Issifou S, Adegnika AA, Sylverken J, Spahlinger D, Ansong D, Lohr SJ, Burchard GD, May J, Mordmuller B, Krishna S, Kremsner PG, Cramer JP, 2014. Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria: a double-center prospective study. J Infect Dis J 209: 1921-1928.
6. Ladhani SD, Patel VS, El Bashir H, 2005. Changes in laboratory features of 192 children with imported falciparum malaria treated with quinine. Pediatr Infect Dis J 24: 1017-1020.
7. World Health Organization. Information Note on Delayed Haemolytic Anaemia following Treatment with Artesunate. Available at: http://www.who.int/malaria/publications/atoz/who-note-delayed-haemolytic-anaemia-oct13.pdf. Accessed February 16, 2014.
8. Medicines for Malaria Venture (MMV). Expert Group Meeting on the Safety Profile of Injectable Artesunate. Available at: http://www.mmv.org/newsroom/events/expert-group-meeting-safety-profile-injectable-artesunate. Accessed February 16, 2014.